Global Opioids Agonist Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
According to our (Global Info Research) latest study, the global Opioids Agonist Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
This report is a detailed and comprehensive analysis for global Opioids Agonist Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Opioids Agonist Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioids Agonist Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioids Agonist Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Purdue Pharma, Titan pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Opioids Agonist Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Opioids Agonist Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids Agonist Drugs, with price, sales, revenue and global market share of Opioids Agonist Drugs from 2018 to 2023.
Chapter 3, the Opioids Agonist Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Agonist Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids Agonist Drugs.
Chapter 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Opioids Agonist Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
This report is a detailed and comprehensive analysis for global Opioids Agonist Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Opioids Agonist Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Opioids Agonist Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioids Agonist Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioids Agonist Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Purdue Pharma, Titan pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Opioids Agonist Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
- Pain Management
- Cough Treatment
- Diarrhea Treatment
- Purdue Pharma
- Titan pharmaceuticals
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.
- Allergan, Plc
- Pfizer Inc
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Opioids Agonist Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids Agonist Drugs, with price, sales, revenue and global market share of Opioids Agonist Drugs from 2018 to 2023.
Chapter 3, the Opioids Agonist Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Agonist Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids Agonist Drugs.
Chapter 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Opioids Agonist Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Agonist Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Codeine
1.3.3 Fentanyl
1.3.4 Meperidine
1.3.5 Methadone
1.3.6 Morphine
1.3.7 Hydrocodone
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Agonist Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pain Management
1.4.3 Cough Treatment
1.4.4 Diarrhea Treatment
1.5 Global Opioids Agonist Drugs Market Size & Forecast
1.5.1 Global Opioids Agonist Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Opioids Agonist Drugs Sales Quantity (2018-2029)
1.5.3 Global Opioids Agonist Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Purdue Pharma
2.1.1 Purdue Pharma Details
2.1.2 Purdue Pharma Major Business
2.1.3 Purdue Pharma Opioids Agonist Drugs Product and Services
2.1.4 Purdue Pharma Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Purdue Pharma Recent Developments/Updates
2.2 Titan pharmaceuticals
2.2.1 Titan pharmaceuticals Details
2.2.2 Titan pharmaceuticals Major Business
2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product and Services
2.2.4 Titan pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Titan pharmaceuticals Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product and Services
2.3.4 Boehringer Ingelheim Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Janssen Pharmaceuticals, Inc Details
2.4.2 Janssen Pharmaceuticals, Inc Major Business
2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
2.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Opioids Agonist Drugs Product and Services
2.5.4 Sanofi Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Sun Pharmaceuticals
2.6.1 Sun Pharmaceuticals Details
2.6.2 Sun Pharmaceuticals Major Business
2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
2.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sun Pharmaceuticals Recent Developments/Updates
2.7 Mallinckrodt Pharmaceuticals
2.7.1 Mallinckrodt Pharmaceuticals Details
2.7.2 Mallinckrodt Pharmaceuticals Major Business
2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
2.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.8 Egalet Corporation
2.8.1 Egalet Corporation Details
2.8.2 Egalet Corporation Major Business
2.8.3 Egalet Corporation Opioids Agonist Drugs Product and Services
2.8.4 Egalet Corporation Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Egalet Corporation Recent Developments/Updates
2.9 Endo Pharmaceuticals Inc.
2.9.1 Endo Pharmaceuticals Inc. Details
2.9.2 Endo Pharmaceuticals Inc. Major Business
2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
2.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Endo Pharmaceuticals Inc. Recent Developments/Updates
2.10 Allergan, Plc
2.10.1 Allergan, Plc Details
2.10.2 Allergan, Plc Major Business
2.10.3 Allergan, Plc Opioids Agonist Drugs Product and Services
2.10.4 Allergan, Plc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Allergan, Plc Recent Developments/Updates
2.11 Pfizer Inc
2.11.1 Pfizer Inc Details
2.11.2 Pfizer Inc Major Business
2.11.3 Pfizer Inc Opioids Agonist Drugs Product and Services
2.11.4 Pfizer Inc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS AGONIST DRUGS BY MANUFACTURER
3.1 Global Opioids Agonist Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Opioids Agonist Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Opioids Agonist Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Opioids Agonist Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2022
3.5 Opioids Agonist Drugs Market: Overall Company Footprint Analysis
3.5.1 Opioids Agonist Drugs Market: Region Footprint
3.5.2 Opioids Agonist Drugs Market: Company Product Type Footprint
3.5.3 Opioids Agonist Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Agonist Drugs Market Size by Region
4.1.1 Global Opioids Agonist Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Opioids Agonist Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Opioids Agonist Drugs Average Price by Region (2018-2029)
4.2 North America Opioids Agonist Drugs Consumption Value (2018-2029)
4.3 Europe Opioids Agonist Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Opioids Agonist Drugs Consumption Value (2018-2029)
4.5 South America Opioids Agonist Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Opioids Agonist Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
5.2 Global Opioids Agonist Drugs Consumption Value by Type (2018-2029)
5.3 Global Opioids Agonist Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
6.2 Global Opioids Agonist Drugs Consumption Value by Application (2018-2029)
6.3 Global Opioids Agonist Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
7.2 North America Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
7.3 North America Opioids Agonist Drugs Market Size by Country
7.3.1 North America Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Opioids Agonist Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Opioids Agonist Drugs Market Size by Country
8.3.1 Europe Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Opioids Agonist Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region
9.3.1 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
10.2 South America Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
10.3 South America Opioids Agonist Drugs Market Size by Country
10.3.1 South America Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Opioids Agonist Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country
11.3.1 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Opioids Agonist Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Opioids Agonist Drugs Market Drivers
12.2 Opioids Agonist Drugs Market Restraints
12.3 Opioids Agonist Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids Agonist Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids Agonist Drugs
13.3 Opioids Agonist Drugs Production Process
13.4 Opioids Agonist Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Agonist Drugs Typical Distributors
14.3 Opioids Agonist Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Opioids Agonist Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Agonist Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Codeine
1.3.3 Fentanyl
1.3.4 Meperidine
1.3.5 Methadone
1.3.6 Morphine
1.3.7 Hydrocodone
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Agonist Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pain Management
1.4.3 Cough Treatment
1.4.4 Diarrhea Treatment
1.5 Global Opioids Agonist Drugs Market Size & Forecast
1.5.1 Global Opioids Agonist Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Opioids Agonist Drugs Sales Quantity (2018-2029)
1.5.3 Global Opioids Agonist Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Purdue Pharma
2.1.1 Purdue Pharma Details
2.1.2 Purdue Pharma Major Business
2.1.3 Purdue Pharma Opioids Agonist Drugs Product and Services
2.1.4 Purdue Pharma Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Purdue Pharma Recent Developments/Updates
2.2 Titan pharmaceuticals
2.2.1 Titan pharmaceuticals Details
2.2.2 Titan pharmaceuticals Major Business
2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product and Services
2.2.4 Titan pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Titan pharmaceuticals Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product and Services
2.3.4 Boehringer Ingelheim Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Janssen Pharmaceuticals, Inc Details
2.4.2 Janssen Pharmaceuticals, Inc Major Business
2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
2.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Opioids Agonist Drugs Product and Services
2.5.4 Sanofi Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Sun Pharmaceuticals
2.6.1 Sun Pharmaceuticals Details
2.6.2 Sun Pharmaceuticals Major Business
2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
2.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sun Pharmaceuticals Recent Developments/Updates
2.7 Mallinckrodt Pharmaceuticals
2.7.1 Mallinckrodt Pharmaceuticals Details
2.7.2 Mallinckrodt Pharmaceuticals Major Business
2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
2.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.8 Egalet Corporation
2.8.1 Egalet Corporation Details
2.8.2 Egalet Corporation Major Business
2.8.3 Egalet Corporation Opioids Agonist Drugs Product and Services
2.8.4 Egalet Corporation Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Egalet Corporation Recent Developments/Updates
2.9 Endo Pharmaceuticals Inc.
2.9.1 Endo Pharmaceuticals Inc. Details
2.9.2 Endo Pharmaceuticals Inc. Major Business
2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
2.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Endo Pharmaceuticals Inc. Recent Developments/Updates
2.10 Allergan, Plc
2.10.1 Allergan, Plc Details
2.10.2 Allergan, Plc Major Business
2.10.3 Allergan, Plc Opioids Agonist Drugs Product and Services
2.10.4 Allergan, Plc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Allergan, Plc Recent Developments/Updates
2.11 Pfizer Inc
2.11.1 Pfizer Inc Details
2.11.2 Pfizer Inc Major Business
2.11.3 Pfizer Inc Opioids Agonist Drugs Product and Services
2.11.4 Pfizer Inc Opioids Agonist Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS AGONIST DRUGS BY MANUFACTURER
3.1 Global Opioids Agonist Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Opioids Agonist Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Opioids Agonist Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Opioids Agonist Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2022
3.5 Opioids Agonist Drugs Market: Overall Company Footprint Analysis
3.5.1 Opioids Agonist Drugs Market: Region Footprint
3.5.2 Opioids Agonist Drugs Market: Company Product Type Footprint
3.5.3 Opioids Agonist Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Agonist Drugs Market Size by Region
4.1.1 Global Opioids Agonist Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Opioids Agonist Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Opioids Agonist Drugs Average Price by Region (2018-2029)
4.2 North America Opioids Agonist Drugs Consumption Value (2018-2029)
4.3 Europe Opioids Agonist Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Opioids Agonist Drugs Consumption Value (2018-2029)
4.5 South America Opioids Agonist Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Opioids Agonist Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
5.2 Global Opioids Agonist Drugs Consumption Value by Type (2018-2029)
5.3 Global Opioids Agonist Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
6.2 Global Opioids Agonist Drugs Consumption Value by Application (2018-2029)
6.3 Global Opioids Agonist Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
7.2 North America Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
7.3 North America Opioids Agonist Drugs Market Size by Country
7.3.1 North America Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Opioids Agonist Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Opioids Agonist Drugs Market Size by Country
8.3.1 Europe Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Opioids Agonist Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region
9.3.1 Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
10.2 South America Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
10.3 South America Opioids Agonist Drugs Market Size by Country
10.3.1 South America Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Opioids Agonist Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country
11.3.1 Middle East & Africa Opioids Agonist Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Opioids Agonist Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Opioids Agonist Drugs Market Drivers
12.2 Opioids Agonist Drugs Market Restraints
12.3 Opioids Agonist Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids Agonist Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids Agonist Drugs
13.3 Opioids Agonist Drugs Production Process
13.4 Opioids Agonist Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Agonist Drugs Typical Distributors
14.3 Opioids Agonist Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioids Agonist Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Opioids Agonist Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Purdue Pharma Major Business
Table 5. Purdue Pharma Opioids Agonist Drugs Product and Services
Table 6. Purdue Pharma Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Purdue Pharma Recent Developments/Updates
Table 8. Titan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Titan pharmaceuticals Major Business
Table 10. Titan pharmaceuticals Opioids Agonist Drugs Product and Services
Table 11. Titan pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Titan pharmaceuticals Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Opioids Agonist Drugs Product and Services
Table 16. Boehringer Ingelheim Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Pharmaceuticals, Inc Major Business
Table 20. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
Table 21. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Janssen Pharmaceuticals, Inc Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Opioids Agonist Drugs Product and Services
Table 26. Sanofi Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceuticals Major Business
Table 30. Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 31. Sun Pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sun Pharmaceuticals Recent Developments/Updates
Table 33. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Mallinckrodt Pharmaceuticals Major Business
Table 35. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 36. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 38. Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Egalet Corporation Major Business
Table 40. Egalet Corporation Opioids Agonist Drugs Product and Services
Table 41. Egalet Corporation Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Egalet Corporation Recent Developments/Updates
Table 43. Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Endo Pharmaceuticals Inc. Major Business
Table 45. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
Table 46. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Endo Pharmaceuticals Inc. Recent Developments/Updates
Table 48. Allergan, Plc Basic Information, Manufacturing Base and Competitors
Table 49. Allergan, Plc Major Business
Table 50. Allergan, Plc Opioids Agonist Drugs Product and Services
Table 51. Allergan, Plc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Allergan, Plc Recent Developments/Updates
Table 53. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc Major Business
Table 55. Pfizer Inc Opioids Agonist Drugs Product and Services
Table 56. Pfizer Inc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc Recent Developments/Updates
Table 58. Global Opioids Agonist Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Opioids Agonist Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Opioids Agonist Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 61. Market Position of Manufacturers in Opioids Agonist Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Opioids Agonist Drugs Production Site of Key Manufacturer
Table 63. Opioids Agonist Drugs Market: Company Product Type Footprint
Table 64. Opioids Agonist Drugs Market: Company Product Application Footprint
Table 65. Opioids Agonist Drugs New Market Entrants and Barriers to Market Entry
Table 66. Opioids Agonist Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Opioids Agonist Drugs Average Price by Region (2018-2023) & (USD/Unit)
Table 72. Global Opioids Agonist Drugs Average Price by Region (2024-2029) & (USD/Unit)
Table 73. Global Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Opioids Agonist Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Opioids Agonist Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Opioids Agonist Drugs Average Price by Type (2018-2023) & (USD/Unit)
Table 78. Global Opioids Agonist Drugs Average Price by Type (2024-2029) & (USD/Unit)
Table 79. Global Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Opioids Agonist Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Opioids Agonist Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Opioids Agonist Drugs Average Price by Application (2018-2023) & (USD/Unit)
Table 84. Global Opioids Agonist Drugs Average Price by Application (2024-2029) & (USD/Unit)
Table 85. North America Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Opioids Agonist Drugs Raw Material
Table 126. Key Manufacturers of Opioids Agonist Drugs Raw Materials
Table 127. Opioids Agonist Drugs Typical Distributors
Table 128. Opioids Agonist Drugs Typical Customers
Table 1. Global Opioids Agonist Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Opioids Agonist Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Purdue Pharma Major Business
Table 5. Purdue Pharma Opioids Agonist Drugs Product and Services
Table 6. Purdue Pharma Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Purdue Pharma Recent Developments/Updates
Table 8. Titan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Titan pharmaceuticals Major Business
Table 10. Titan pharmaceuticals Opioids Agonist Drugs Product and Services
Table 11. Titan pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Titan pharmaceuticals Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Opioids Agonist Drugs Product and Services
Table 16. Boehringer Ingelheim Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Pharmaceuticals, Inc Major Business
Table 20. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
Table 21. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Janssen Pharmaceuticals, Inc Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Opioids Agonist Drugs Product and Services
Table 26. Sanofi Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceuticals Major Business
Table 30. Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 31. Sun Pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sun Pharmaceuticals Recent Developments/Updates
Table 33. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Mallinckrodt Pharmaceuticals Major Business
Table 35. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 36. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 38. Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Egalet Corporation Major Business
Table 40. Egalet Corporation Opioids Agonist Drugs Product and Services
Table 41. Egalet Corporation Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Egalet Corporation Recent Developments/Updates
Table 43. Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Endo Pharmaceuticals Inc. Major Business
Table 45. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
Table 46. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Endo Pharmaceuticals Inc. Recent Developments/Updates
Table 48. Allergan, Plc Basic Information, Manufacturing Base and Competitors
Table 49. Allergan, Plc Major Business
Table 50. Allergan, Plc Opioids Agonist Drugs Product and Services
Table 51. Allergan, Plc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Allergan, Plc Recent Developments/Updates
Table 53. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc Major Business
Table 55. Pfizer Inc Opioids Agonist Drugs Product and Services
Table 56. Pfizer Inc Opioids Agonist Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc Recent Developments/Updates
Table 58. Global Opioids Agonist Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Opioids Agonist Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Opioids Agonist Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 61. Market Position of Manufacturers in Opioids Agonist Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Opioids Agonist Drugs Production Site of Key Manufacturer
Table 63. Opioids Agonist Drugs Market: Company Product Type Footprint
Table 64. Opioids Agonist Drugs Market: Company Product Application Footprint
Table 65. Opioids Agonist Drugs New Market Entrants and Barriers to Market Entry
Table 66. Opioids Agonist Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Opioids Agonist Drugs Average Price by Region (2018-2023) & (USD/Unit)
Table 72. Global Opioids Agonist Drugs Average Price by Region (2024-2029) & (USD/Unit)
Table 73. Global Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Opioids Agonist Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Opioids Agonist Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Opioids Agonist Drugs Average Price by Type (2018-2023) & (USD/Unit)
Table 78. Global Opioids Agonist Drugs Average Price by Type (2024-2029) & (USD/Unit)
Table 79. Global Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Opioids Agonist Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Opioids Agonist Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Opioids Agonist Drugs Average Price by Application (2018-2023) & (USD/Unit)
Table 84. Global Opioids Agonist Drugs Average Price by Application (2024-2029) & (USD/Unit)
Table 85. North America Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Opioids Agonist Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Opioids Agonist Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Opioids Agonist Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Opioids Agonist Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Opioids Agonist Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Opioids Agonist Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Opioids Agonist Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Opioids Agonist Drugs Raw Material
Table 126. Key Manufacturers of Opioids Agonist Drugs Raw Materials
Table 127. Opioids Agonist Drugs Typical Distributors
Table 128. Opioids Agonist Drugs Typical Customers
LIST OF FIGURES
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Opioids Agonist Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Opioids Agonist Drugs Consumption Value Market Share by Type in 2022
Figure 4. Codeine Examples
Figure 5. Fentanyl Examples
Figure 6. Meperidine Examples
Figure 7. Methadone Examples
Figure 8. Morphine Examples
Figure 9. Hydrocodone Examples
Figure 10. Global Opioids Agonist Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Opioids Agonist Drugs Consumption Value Market Share by Application in 2022
Figure 12. Pain Management Examples
Figure 13. Cough Treatment Examples
Figure 14. Diarrhea Treatment Examples
Figure 15. Global Opioids Agonist Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Opioids Agonist Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Opioids Agonist Drugs Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Opioids Agonist Drugs Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Opioids Agonist Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Opioids Agonist Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Opioids Agonist Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Opioids Agonist Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Opioids Agonist Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Opioids Agonist Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Opioids Agonist Drugs Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Opioids Agonist Drugs Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Opioids Agonist Drugs Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 57. China Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Opioids Agonist Drugs Market Drivers
Figure 78. Opioids Agonist Drugs Market Restraints
Figure 79. Opioids Agonist Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs in 2022
Figure 82. Manufacturing Process Analysis of Opioids Agonist Drugs
Figure 83. Opioids Agonist Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Opioids Agonist Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Opioids Agonist Drugs Consumption Value Market Share by Type in 2022
Figure 4. Codeine Examples
Figure 5. Fentanyl Examples
Figure 6. Meperidine Examples
Figure 7. Methadone Examples
Figure 8. Morphine Examples
Figure 9. Hydrocodone Examples
Figure 10. Global Opioids Agonist Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Opioids Agonist Drugs Consumption Value Market Share by Application in 2022
Figure 12. Pain Management Examples
Figure 13. Cough Treatment Examples
Figure 14. Diarrhea Treatment Examples
Figure 15. Global Opioids Agonist Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Opioids Agonist Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Opioids Agonist Drugs Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Opioids Agonist Drugs Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Opioids Agonist Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Opioids Agonist Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Opioids Agonist Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Opioids Agonist Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Opioids Agonist Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Opioids Agonist Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Opioids Agonist Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Opioids Agonist Drugs Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Opioids Agonist Drugs Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Opioids Agonist Drugs Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 57. China Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Opioids Agonist Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Opioids Agonist Drugs Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Opioids Agonist Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Opioids Agonist Drugs Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Opioids Agonist Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Opioids Agonist Drugs Market Drivers
Figure 78. Opioids Agonist Drugs Market Restraints
Figure 79. Opioids Agonist Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs in 2022
Figure 82. Manufacturing Process Analysis of Opioids Agonist Drugs
Figure 83. Opioids Agonist Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
